Posted on October 2, 2019 by Sitemaster
It is with great regret that we must report the demise — last Saturday — of Dr. Gerald (“Gerry”) Chodak — formerly a professor of urology at the University of Chicago Pritzker School of Medicine. … READ MORE …
Filed under: Uncategorized | Tagged: Chodak, death, Gerald | 7 Comments »
Posted on January 17, 2018 by Sitemaster
Two questions that come up regularly are whether: (a) men who are said to have died of prostate cancer actually did, and (b) men with prostate cancer who are said to have died of something else actually died of their prostate cancer. … READ MORE …
Filed under: Uncategorized | Tagged: accuracy, cancer-specific, cause, death, mortality | 4 Comments »
Posted on December 1, 2017 by Sitemaster
Bayer is to unblind data early from an ongoing randomized clinical trial of radium-223 acetate — on the guidance of the trial’s Independent Data Monitoring Committee (IDMC). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, death, facture, radium-223, risk, safety, trial, Xofigo, Zytiga | Leave a comment »
Posted on September 21, 2017 by Sitemaster
A large, newly published, observational study has suggested that comorbidity affects other-cause mortality but not prostate cancer-specific mortality after accounting for patient and tumor characteristics and treatment type. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: comorbidity, death, mortality, risk, Treatment | 3 Comments »
Posted on August 30, 2017 by Sitemaster
There are very few good and thorough clinical studies on the use and the long-term effectiveness or efficacy of alternative forms of medicine in the treatment of cancer (let alone the treatment of prostate cancer specifically). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: alternative, death, medicine, risk, utilization | 3 Comments »
Posted on June 15, 2017 by Sitemaster
According to an article from Kaiser Health News on the CNN web site today, “People with advanced cancer don’t know enough about their disease to make informed decisions about treatment or how they want to spend their remaining time.” … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: death, expectations, illness, realities, terminal | 18 Comments »
Posted on May 18, 2017 by Sitemaster
One of the abstracts to be presented at ASCO this year gives us some insight into risk for and time to death among men with non-metastatic but castration-resistant prostate cancer (nmCRPC). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, death, metastasis, nmCRPC, nonmetastatic, risk, time | 20 Comments »
Posted on March 8, 2017 by Sitemaster
New data derived from the Physicans’ Health Study have suggested that there is an association between regular aspirin use and avoidance of risk for lethal forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aspirin, death, lethal, risk | 4 Comments »
Posted on January 25, 2017 by Sitemaster
It’s a question every prostate cancer patient wants an answer to: “OK doc. I get it. But how long am I gonna live with this?”
It’s also a question that doctors have a very great deal of difficulty answering, for a whole bunch of reasons. So … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: death, mortality, prognosis, risk | 2 Comments »
Posted on May 24, 2016 by Sitemaster
Your sitemaster is intimately familiar with the human capacity for denial and avoidance. As someone who has spent much of his life writing for a living, he knows all too well his capacity for avoiding some topics until he absolutely has to deal with them! … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: avoidance, communication, death, denial, knowledge, risk | 12 Comments »
Posted on January 4, 2016 by Sitemaster
Despite all the prostate cancer research over the past 30 or so years, we still have limited information about the clinical and therapeutic history of prostate cancer in men who have progressive disease and go on to die of metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: castration-resistant, clinical, death, history, mCRPC, metastatic, therapeutic | 4 Comments »
Posted on October 7, 2015 by Sitemaster
Alas, as most of our readers are all too well aware, some 30,000 or more men in America will die from prostate cancer this year and next year and on into the future, unless and until we find some radically new types of treatment. However, … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: death, planning, question, risk, surprise | 7 Comments »
Posted on March 26, 2015 by Sitemaster
A paper presented at the annual meeting of the European Association of Urology (EAU) suggests that high-risk prostate cancer patients < 60 years of age at the time of radical prostatectomy are more likely to die from their cancer than from other causes during the first 10 years after their surgery. But after that, other causes of death become more likely. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: "high risk", death, mortality, risk, surgery | Leave a comment »
Posted on October 3, 2014 by Sitemaster
A new paper just published in European Urology offers further evidence from a meta-analysis of data from 51 different primary papers that smoking tobacco does increase a man’s risk of dying from prostate cancer — by about 24 percent compared to the risk for non-smokers. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: death, mortality, risk, smoking | Leave a comment »
Posted on August 18, 2014 by Sitemaster
According to a report in the Daily Telegraph, Cancer Research UK is claiming that deaths from prostate cancer in the UK have drop by 20.8 percent during the 19-year period from 1991-93 to 2010-12. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: death, mortality, rate, UK | 1 Comment »